MLTX
Price
$35.44
Change
-$1.77 (-4.76%)
Updated
Apr 7, 02:48 PM (EDT)
Capitalization
2.35B
31 days until earnings call
PLX
Price
$2.38
Change
-$0.01 (-0.42%)
Updated
Apr 7, 02:53 PM (EDT)
Capitalization
186.5M
32 days until earnings call
Ad is loading...

MLTX vs PLX

Header iconMLTX vs PLX Comparison
Open Charts MLTX vs PLXBanner chart's image
MoonLake Immunotherapeutics
Price$35.44
Change-$1.77 (-4.76%)
Volume$1.12K
Capitalization2.35B
Protalix BioTherapeutics
Price$2.38
Change-$0.01 (-0.42%)
Volume$800
Capitalization186.5M
MLTX vs PLX Comparison Chart
Loading...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MLTX vs. PLX commentary
Apr 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLTX is a Buy and PLX is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 07, 2025
Stock price -- (MLTX: $37.21 vs. PLX: $2.39)
Brand notoriety: MLTX and PLX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLTX: 120% vs. PLX: 124%
Market capitalization -- MLTX: $2.35B vs. PLX: $186.5M
MLTX [@Biotechnology] is valued at $2.35B. PLX’s [@Biotechnology] market capitalization is $186.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $283.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLTX’s FA Score shows that 0 FA rating(s) are green whilePLX’s FA Score has 1 green FA rating(s).

  • MLTX’s FA Score: 0 green, 5 red.
  • PLX’s FA Score: 1 green, 4 red.
According to our system of comparison, PLX is a better buy in the long-term than MLTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLTX’s TA Score shows that 4 TA indicator(s) are bullish while PLX’s TA Score has 4 bullish TA indicator(s).

  • MLTX’s TA Score: 4 bullish, 4 bearish.
  • PLX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than PLX.

Price Growth

MLTX (@Biotechnology) experienced а -6.65% price change this week, while PLX (@Biotechnology) price change was -7.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.52%. For the same industry, the average monthly price growth was -18.01%, and the average quarterly price growth was -17.38%.

Reported Earning Dates

MLTX is expected to report earnings on Aug 07, 2025.

PLX is expected to report earnings on May 09, 2025.

Industries' Descriptions

@Biotechnology (-9.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($2.36B) has a higher market cap than PLX($186M). PLX YTD gains are higher at: 27.128 vs. MLTX (-31.283). PLX has higher annual earnings (EBITDA): -6.48M vs. MLTX (-141.71M). MLTX has more cash in the bank: 448M vs. PLX (27.4M). MLTX has less debt than PLX: MLTX (2.83M) vs PLX (5.68M). PLX has higher revenues than MLTX: PLX (45.7M) vs MLTX (0).
MLTXPLXMLTX / PLX
Capitalization2.36B186M1,266%
EBITDA-141.71M-6.48M2,189%
Gain YTD-31.28327.128-115%
P/E RatioN/A59.75-
Revenue045.7M-
Total Cash448M27.4M1,635%
Total Debt2.83M5.68M50%
FUNDAMENTALS RATINGS
PLX: Fundamental Ratings
PLX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
98
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MLTXPLX
RSI
ODDS (%)
Bullish Trend 4 days ago
36%
Bullish Trend 4 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
67%
Bearish Trend 4 days ago
72%
Momentum
ODDS (%)
Bearish Trend 4 days ago
52%
Bearish Trend 4 days ago
72%
MACD
ODDS (%)
Bearish Trend 4 days ago
57%
Bullish Trend 4 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
57%
Bearish Trend 4 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
56%
Bullish Trend 4 days ago
80%
Advances
ODDS (%)
Bullish Trend 11 days ago
81%
Bullish Trend 5 days ago
84%
Declines
ODDS (%)
Bearish Trend 7 days ago
72%
Bearish Trend 7 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
83%
Aroon
ODDS (%)
Bearish Trend 4 days ago
55%
Bearish Trend 4 days ago
83%
View a ticker or compare two or three
Ad is loading...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
KCSIX10.89-0.53
-4.64%
Knights of Columbus Small Cap I
NMFAX12.75-0.73
-5.42%
Nationwide BNY Mellon Dyn US Core A
NMIMX23.56-1.40
-5.61%
Columbia Large Cap Enhanced Core Inst
RGELX9.45-0.60
-5.97%
RBC Global Equity Leaders A
NOINX13.80-0.90
-6.12%
Northern International Equity Index

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been loosely correlated with XENE. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if MLTX jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
-2.23%
XENE - MLTX
47%
Loosely correlated
-4.27%
CLDX - MLTX
42%
Loosely correlated
-7.99%
DNLI - MLTX
41%
Loosely correlated
-7.90%
IDYA - MLTX
40%
Loosely correlated
-5.52%
KYMR - MLTX
38%
Loosely correlated
-6.84%
More

PLX and

Correlation & Price change

A.I.dvisor tells us that PLX and ZNTL have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PLX and ZNTL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLX
1D Price
Change %
PLX100%
-8.08%
ZNTL - PLX
31%
Poorly correlated
-8.95%
CPRX - PLX
31%
Poorly correlated
-5.68%
SNDX - PLX
31%
Poorly correlated
-9.71%
LXRX - PLX
31%
Poorly correlated
-5.48%
MLTX - PLX
30%
Poorly correlated
-2.23%
More